loratadine paten - Loratadine Drug Targets Indications Patents Synapse hatamogi Patsnap The first generic version for Loratadine was by Pld Acquisitions Llc and was approved on Jan 21 2003 And the latest generic version is by Marksans Pharma Ltd and was approved on Nov 21 2024 Given below is the list of companies who have filed for Loratadine generic along with the locations of their manufacturing plants worldwide Loratadine Uses Dosage Side Effects Guide Drugscom A process for the manufacturing of loratadine and its PubChem Generic LORATADINE INN entry pharmaceutical patent expiry and freedom The invention discloses loratadine syrup and a preparation method thereof According to the syrup with loratadine as a main medicine betacyclodextrin or gammacyclodextrin as an inclusion agent citrate or sodium citrate as a pH regulator and a grapefruit essence or an orange essence as a corrective agent on the basis of the parts by weight each 100 parts of the main medicine is matched What are the generic drug sources for loratadine and what is the scope of patent protection Loratadine is the generic ingredient in eleven branded drugs marketed by Bayer Healthcare Llc Aurobindo Pharma Bionpharma Marksans Pharma Strides Pharma Taro Aurobindo Pharma Ltd Hetero Labs Ltd Iii Lannett Co Inc Perrigo Pharm Assoc Ranbaxy Loratadine prepared in accordance with the present invention contains less than about 05 or less than about 01 by weight of individual impurities like the loratadine bromo impurity and the loratadine dehydro impurity as characterized by a high performance liquid chromatography HPLC chromatogram obtained from a mixture comprising A process for the manufacturing of loratadine and its Google Patents Loratadine is an antihistamine and is used to treat the symptoms of allergies such as sneezing watery eyes and runny nose Includes loratadine side effects interactions and indications Generic name loratadine lorATadeen Brand names Alavert Claritin US Patent virtusplay for Antihistamine formulations for Justia Patents Search Generic LORATADINE INN entry drug patent expiration information and Loratadine syrup and preparation method thereof Google Patents Loratadine is the generic ingredient in eleven branded drugs marketed by Bayer Healthcare Llc Aurobindo Pharma Bionpharma Marksans Pharma Strides Pharma Taro Aurobindo Pharma Ltd Hetero Labs Ltd Iii Lannett Co Inc Perrigo Pharm Assoc Ranbaxy Labs Ltd Teva Wockhardt Bio Ag Perrigo Pharma Intl Sun Pharm Fdn Consumer Actavis Labs US20080194823A1 Preparation of loratadine form i Google Patents Loratadine was patented in 1980 and first became available in 1988 It is listed as an essential medication by the World Health Organization and is available as a generic In the US it can be purchased over the counter and was one of the most commonly prescribed medications in 2020 with over 9 million prescriptions The loratadine compositions exhibit good solubility and storage stability while maintaining bioavailability of the drug The compositions also permit high concentrations of solubilized loratadine per total fill volume and thereby permit the use of smaller capsules to deliver the same dosage of drug CIP of US patent application Ser No Drug Patents containing Loratadine GreyB US patent 4731447 447 advocates the synthetic route for loratadine US 447 claims advantage of reduction in number of steps from 6 to 5 and bypassing using Grignard Reagent In accordance with column 7 lines 20 to 25 hazardous chemical such as nbutyl lithium is used under nitrogen atmosphere during reaction of respective carboxamide WO2006006184A3 chemical patent summary Loratadine can also be prepared by treating cayano compound with organometallic compound containing Mg to produce a ketone by the methods known in the art followed by cyclising in presence of a mixture of sulfuric acid and a source of boric acid to get Nmethyl product ayam semur and converting to loratadine
gebyar124
emultifinance
